Your Good Partner in Biology Research

  1. 首页
  2. 试剂盒
  3. 酶联免疫试剂盒
  4. Human Insulin-like growth factor-binding protein 6(IGFBP6) ELISA kit

Human Insulin-like growth factor-binding protein 6(IGFBP6) ELISA kit

  • 中文名称：
    人胰岛素样生长因子结合蛋白6(IGFBP6)酶联免疫试剂盒
  • 货号：
    CSB-EL011100HU
  • 规格：
    96T/48T
  • 价格：
    ￥3600/￥2500
  • 其他：

产品详情

  • 产品描述：
        IGFBP6（Insulin-like growth factor-binding protein 6）是一种与IGF-1和IGF-2结合的载体蛋白，属于胰岛素样生长因子结合蛋白家族，主要在骨骼系统中表达，对骨形态和骨代谢具有重要作用。IGFBP6的结合作用可以影响IGF的生物利用度，从而影响骨细胞的代谢和功能，对于骨生长和修复具有重要作用。此外，IGFBP6还与多种肿瘤相关，如乳腺癌、卵巢癌、前列腺癌等，其含量与肿瘤的进展和预后相关。
        j9九游会登录入口首页生物所提供的Human Insulin-like growth factor-binding protein 6(IGFBP6) ELISA kit属于ELISA检测试剂盒，采用双抗夹心法定量检测人血清、血浆,组织匀浆样本中的IGFBP6，其灵敏度为0.195 ng/mL，检测范围为0.78 ng/mL-50 ng/mL。
     
  • 别名：
    IBP 6 ELISA Kit; IBP-6 ELISA Kit; IBP6 ELISA Kit; IBP6_HUMAN ELISA Kit; IGF binding protein 6 ELISA Kit; IGF-binding protein 6 ELISA Kit; IGFBP 6 ELISA Kit; IGFBP-6 ELISA Kit; IGFBP6 ELISA Kit; Insulin like growth factor binding protein 6 ELISA Kit; Insulin-like growth factor-binding protein 6 ELISA Kit
  • 缩写：
    IGFBP6
  • Uniprot No.：
  • 种属：
    Homo sapiens (Human)
  • 样本类型：
    serum, plasma,tissue homogenates
  • 检测范围：
    0.78 ng/mL-50 ng/mL
  • 灵敏度：
    0.195 ng/mL
  • 反应时间：
    1-5h
  • 样本体积：
    50-100ul
  • 检测波长：
    450 nm
  • 研究领域：
    Signal Transduction
  • 测定原理：
    quantitative
  • 测定方法：
    Sandwich
  • 数据处理：
  • 货期：
    3-5 working days

产品评价

靶点详情

  • 最新研究进展：
    IGFBP6的最新研究表明，它可能参与了神经系统的发育和功能。一项研究发现，IGFBP6可以促进神经元的生成和神经元的细胞周期进程。另外，IGFBP6也被发现可以通过影响细胞的能量代谢和凋亡过程来调节癌细胞的增殖和生存。
  • 功能：
    IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Activates the MAPK signaling pathway and induces cell migration.
  • 基因功能参考文献：
    1. A decrease of IGFBP6 expression can involve a decrease in the expression of N-cadherin and transcription factor Slug. PMID: 29577195
    2. IGFBP-6 could inhibit invasion and migration of colorectal carcinoma cells PMID: 29439316
    3. IGFBP6 might be an important regulator and prognostic factor for glioma. PMID: 27650075
    4. Results suggest that insulin like growth factor binding protein 6 (IGFBP6) may be an independent prognostic biomarker for nasopharyngeal carcinoma (NPC). PMID: 27623076
    5. We identified a novel SNP variant, Chr12:g.53494591T>C. c.T430C (p.S144P) in the insulin-like growth factor binding protein-6 (IGFBP6) gene. This variant was shared by all affected family members, but not by unaffected members. The c.T430C (p.S144P) variant of IGFBP6 was identified as the likely causal variant associated with increased risk of familial disc degeneration in the studied pedigree. PMID: 28829625
    6. We found that IGFBP6 and SATB2 were significantly down-regulated in HIV-infected CEM*174 cells and 3 different cohorts of HIV/AIDS patients while their promoters were predominantly hyper-methylated compared with normal controls. PMID: 26039376
    7. IGFBP6 attenuation in ACTH-secreting pituitary adenomas is associated with tumor growth, through activation of PI3K-AKT-mTOR pathway PMID: 24379119
    8. CCL-18 and IGFBP-6 were identified as new potential serum biomarkers for prostate cancer. PMID: 24747338
    9. When the concentrations of IGFBP-6 or KNG1 were greater than 98.5 pg/ml or 88.5 ng/ml, respectively, they predicted the proliferative vitreoretinopathy prognosis. PMID: 23808406
    10. Data indicate that IGFBP-6 binds to prohibitin-2 on the cell membrane, and knockdown of the latter abrogates IGFBP-6-induced migration. PMID: 24003225
    11. Review of the IGF system in physiology and disease with a focus on the regulation and actions of IGFBP-6, and its potential roles in cancer cells. PMID: 23126425
    12. These results suggest that the expression of IGFBP-6 in vascular endothelial cells is up-regulated by hypoxia and IGFBP-6 inhibits angiogenesis in vitro and in vivo PMID: 21618524
    13. IGFBP-6 acts as a inhibitory mediator of thyroid hormone effects in osteoblast differentiation PMID: 21997736
    14. TCDD at low concentrations may have a negative effect on cell apoptosis and down-regulate gene expression of IGFBP-6 in SaOS-2 cells. PMID: 18724896
    15. Hh pathway is aberrant activation in colorectal carcinoma cell line. Its inhibitor may be effectual agent for colorectal cancer chemoprevention. Gli1 maintained cell survival by binding promoter regions and facilitating transcription of IGFBP6 and Bcl-2. PMID: 21940310
    16. When IGFBP-6 gene expression was downregulated, cell proliferation was inhibited and apoptotic cell death was increased. PMID: 21820463
    17. Kininogen-1 and IGFBP-6 are expressed in serum and vitreous humor in proliferative vitreoretinopathy patients. PMID: 21054968
    18. IGFBP-6 inhibits osteoblastic differentiation mediated by vitamin d3 by directly binding the vitamin d receptor and inhibiting its function PMID: 21458526
    19. These results indicate that IGFBP-6 promotes Rh30 rhabdomyosarcoma chemotaxis in an IGF-independent manner, and that MAPK signaling pathways and their cross-talk play an important role in this process. PMID: 20432455
    20. Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insulin-like growth factor binding protein-6. PMID: 11914024
    21. may function as an antiproliferative molecule suppressing mitogenic effects of insulin-like growth factors on Malassez cells PMID: 12558805
    22. CCI-779 acts additively with IGFBP-6 to reduce rhabdomyosarcoma growth both in vitro and in vivo. PMID: 14710364
    23. C-domain of IGFBP-6 consists of a thyroglobulin type 1 fold comprising an alpha-helix followed by a loop, a three-stranded antiparallel beta-sheet incorporating a second loop, and a disulfide-bonded flexible third loop. PMID: 15308688
    24. A close correlation exists between residues of the carboxyl-terminal domain of IGFBP6 undergoing conformational change in 15N NMR spectroscopy studies with those that disappeared or broadened upon insulin-like growth factor (IGF-II) binding. PMID: 15366928
    25. The IGFBP-6 protein is synthesized as propeptides with a hydrophobic leader sequence, removal of which yields a mature protein composed of 3 recognizable domains of similar size. PMID: 15797461
    26. transgenic human IGFBP-6 mice may be considered a new tool for studies of the involvement of the brain IGF system in metabolism control and obesity. PMID: 15889232
    27. p38 MAPK is involved in IGFBP-6-induced IGF-independent rhabdomyosarcoma cell migration PMID: 17519236
    28. Toxic effect of TCDD on osteogenesis through altering IGFBP6 gene expression in osteoblasts is reported. PMID: 17978469
    29. IGFBP-6 is translocated to the nucleus with functional consequences, and different members of the IGFBP family have specific nuclear import mechanisms. PMID: 18039785
    30. These studies provide evidence that overexpression of IGFBP-6 suppresses human and murine osteoblast differentiation, that IGFBP-6 and LMP-1 physically interact, and supports the conclusion that this interaction may be functionally relevant. PMID: 18395833
    31. bexarotene increased the occupancy of the identified enhancer element in IGFBP-6 gene by RXRalpha, RARbeta, cJun, cFos, and p300 PMID: 18957410
    32. Data show that an increase in JNK activation in the presence of NFkappaB inhibition significantly increased the expression of IGFBP6. PMID: 18982452
    33. IGFBP-6 is the effector of tumor suppressor activity of SEMA3B. PMID: 18985860

    显示更多

    收起更多

  • 亚细胞定位：
    Secreted.
  • 数据库链接：

    HGNC: 5475

    OMIM: 146735

    KEGG: hsa:3489

    STRING: 9606.ENSP00000301464

    UniGene: Hs.274313